Search results for "Neuroglia"

showing 10 items of 143 documents

Inhibition of glial proliferation in vitro by serum from patients with multiple sclerosis

1987

Primary cell cultures from fetal rat CNS have been employed to evaluate the effects caused by the addition of serum from patients affected by multiple sclerosis (MS). MS-serum supplemented media caused a decrease in [3H]-thymidine incorporation into the cultures, thus indicating an inhibitory effect on proliferating glial cells. Sera from patients in remission stage of the disease showed an inhibitory effect not significatively lower than those from patients in acute stage. These results suggest that glial cells may be a target of circulating factors present in MS.

AdultMalemedicine.medical_specialtyPathologyMultiple SclerosisDiseaseBiologyTritiumSettore BIO/19 - Microbiologia GeneraleInternal medicineSettore BIO/10 - BiochimicamedicineAnimalsHumansCells CulturedFetusNeuroscience (all)Cell growthMultiple sclerosisGeneral MedicineMiddle Agedmedicine.diseaseIn vitroAcute stageRatsEndocrinologymedicine.anatomical_structureNeurologyCell cultureNeurogliaFemaleSettore MED/26 - NeurologiaNeurology (clinical)NeurogliaCell DivisionThymidine
researchProduct

Function of Glia in Aging and the Brain Diseases.

2019

Microglia cells during aging, neurodegeneration and neuroinflammation show different morphological and transcriptional profiles (related to axonal direction and cell adhesion). Furthermore, expressions of the receptors on the surface and actin formation compared to young are also different. This review delves into the role of glia during aging and the development of the diseases. The susceptibility of different regions of the brain to disease are linked to the overstimulation of signals related to the immune system during aging, as well as the damaging impact of these cascades on the functionality of different populations of microglia present in each region of the brain. Furthermore, a decr…

AgingDiseaseReviewBiologyBlood–brain barrier03 medical and health sciences0302 clinical medicineImmune systemmedicineHumansCell adhesionReceptorNeuroinflammationBrain DiseasesMicrogliaglia.NeurodegenerationBrainGeneral Medicinemedicine.diseasemedicine.anatomical_structureGene Expression RegulationBlood-Brain Barrier030211 gastroenterology & hepatologyMicrogliaNeuroscienceNeuroglia
researchProduct

Adrenergic activation of phospholipase D in primary rat astrocytes.

1996

Phospholipase D (PLD) activity was investigated in astrocytes prepared from newborn rat cerebral cortex using the transphosphatidylation assay. Basal PLD activity was measurable and was found to be enhanced by ATP, carbachol and noradrenaline. The activation by noradrenaline (EC50, 0.68 microM) was mimicked by methoxamine (EC50, 65 microM), an alpha 1-specific adrenergic agonist, and was inhibited by prazosine, an alpha 1-specific adrenergic antagonist. Clonidin, an alpha 2-adrenergic agonist, slightly lowered PLD activity whereas beta-adrenergic drugs were without effect. Experiments with mitogens indicate that PLD activation in astrocytes may be involved in the control of astrocytic cell …

Agonistmedicine.medical_specialtyCarbacholmedicine.drug_classAdrenergicBiologyMethoxamineMethoxamineNorepinephrineInternal medicinemedicineAdrenergic antagonistPhospholipase DAnimalsAdrenergic agonistCells CulturedDose-Response Relationship DrugPhospholipase DGeneral NeuroscienceRatsenzymes and coenzymes (carbohydrates)Endocrinologymedicine.anatomical_structureAstrocytesNeuroglialipids (amino acids peptides and proteins)medicine.drugNeuroscience letters
researchProduct

Adaptogens in chemobrain (Part II): Effect of plant extracts on chemotherapy-induced cytotoxicity in neuroglia cells

2019

Abstract Background Cancer chemotherapy-induced cognitive impairments are apparently associated with harmful effects on physiological functions of brain cells. Adaptogens, are known to exhibit neuroprotective effects and to increase cognitive functions in clinical studies. In our previous study (Seo et al., 2018), we demonstrated that selected adaptogenic extracts significantly attenuate cytostatic-induced regulation of more than 100 genes involved in the activation of neuronal death and inhibiting neurogenesis. Neuroprotective and cytoprotective activities of adaptogens rise the question about their possible impact on cytostatic effects of a chemotherapeutic combination of 5-fluorouracil, …

AndrographolidePharmaceutical ScienceEleutherococcusPharmacologyNeuroprotectionCell Linelaw.invention03 medical and health scienceschemistry.chemical_compound0302 clinical medicinelawAntineoplastic Combined Chemotherapy ProtocolsDrug DiscoveryRhodiolamedicineHumansCytotoxic T cellCytotoxicityCyclophosphamideEpirubicin030304 developmental biologyPharmacology0303 health sciencesDose-Response Relationship DrugbiologyPlant ExtractsNeurotoxicitybiology.organism_classificationmedicine.diseaseNeuroprotective AgentsComplementary and alternative medicinechemistry030220 oncology & carcinogenesisMolecular MedicineAndrographisRhodiolaFluorouracilPhytotherapyNeurogliaEpirubicinmedicine.drugPhytomedicine
researchProduct

Glutathione metabolism in primary astrocyte cultures: flow cytometric evidence of heterogeneous distribution of GSH content.

1993

The time-course of intracellular glutathione (GSH) values after incubation with L-buthionine-(S,R)-sulfoximine (BSO), a selective inhibitor of gamma-glutamylcysteine synthetase, showed that glutathione turns over with a half-life of 5 h. Intracellular GSH was assayed by flow cytometry using three different methods. Astrocytes showed a narrow range of cellular size but a wide range of intracellular GSH. This heterogeneity was resolved into three distinct subpopulations which represent 20%, 35% and 45% of the total astrocyte number. The less abundant subpopulation had the lower GSH content, while the most abundant was the subpopulation with the higher content. Over 95% of astrocytes were in t…

AntimetabolitesNerve Tissue ProteinsBiologyFlow cytometrychemistry.chemical_compoundCytosolMethionine SulfoximinemedicineAnimalsButhionine sulfoximineRats WistarMolecular BiologyButhionine SulfoximineCells CulturedBrain ChemistryCerebral Cortexmedicine.diagnostic_testGeneral NeuroscienceCell CycleGlutathioneMetabolismDNAHydrogen-Ion ConcentrationFlow CytometryGlutathioneRatsCytosolmedicine.anatomical_structurechemistryBiochemistryAnimals NewbornAstrocytesNeurogliaNeurology (clinical)IntracellularDevelopmental BiologyAstrocyteHalf-LifeBrain research
researchProduct

Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothal…

2015

Endocannabinoids participate in the control of neurogenesis, neural cell death and gliosis. The pharmacological effect of the fatty acid amide hydrolase (FAAH) inhibitor URB597, which limits the endocannabinoid degradation, was investigated in the present study. Cell proliferation (phospho-H3(+) or BrdU(+) cells) of the main adult neurogenic zones as well as apoptosis (cleaved caspase-3(+)), astroglia (GFAP(+)), and microglia (Iba1(+) cells) were analyzed in the hippocampus, hypothalamus and striatum of rats intraperitoneally treated with URB597 (0.3 mg/kg/day) at one dose/4-days resting or 5 doses (1 dose/day). Repeated URB597 treatment increased the plasma levels of the N-acylethanolamine…

AstrocitosNeurobiologia del desenvolupamentAmidohidrolasasCannabinoid receptorCarbamatos:Chemicals and Drugs::Amino Acids Peptides and Proteins::Proteins::Intracellular Signaling Peptides and Proteins::Apoptosis Regulatory Proteins::Caspases [Medical Subject Headings]:Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Differentiation::Neurogenesis [Medical Subject Headings]medicine.medical_treatment:Chemicals and Drugs::Carbohydrates::Monosaccharides::Hexoses::Glucose [Medical Subject Headings]Apoptosis:Phenomena and Processes::Physiological Phenomena::Body Constitution::Body Weights and Measures::Body Size::Body Weight [Medical Subject Headings]chemistry.chemical_compound:Chemicals and Drugs::Amino Acids Peptides and Proteins::Proteins::Membrane Proteins::Receptors Cell Surface::Receptors G-Protein-Coupled::Receptors Cannabinoid::Receptor Cannabinoid CB1 [Medical Subject Headings]0302 clinical medicine:Chemicals and Drugs::Organic Chemicals::Carboxylic Acids::Acids Acyclic::Carbamates [Medical Subject Headings]Fatty acid amide hydrolaseReceptor cannabinoide CB1:Organisms::Eukaryota::Animals [Medical Subject Headings]FAAHGliosishealth care economics and organizations:Chemicals and Drugs::Nucleic Acids Nucleotides and Nucleosides::Nucleosides::Deoxyribonucleosides::Deoxyuridine::Bromodeoxyuridine [Medical Subject Headings]:Chemicals and Drugs::Lipids::Glycerides::Triglycerides [Medical Subject Headings]Original Research0303 health sciencesNeurogenesisBenzamidas:Chemicals and Drugs::Polycyclic Compounds::Steroids::Cholestanes::Cholestenes::Cholesterol [Medical Subject Headings]Endocannabinoid systemEtanolaminas3. Good healthEndocannabinoides:Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids Unsaturated::Fatty Acids Monounsaturated::Oleic Acids [Medical Subject Headings]CannabinoidesMicroglíalipids (amino acids peptides and proteins)medicine.symptomColesterol:Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Terpenes::Cannabinoids [Medical Subject Headings]:Chemicals and Drugs::Lipids::Fatty Acids::Palmitic Acids [Medical Subject Headings]psychological phenomena and processesProliferación celularmedicine.medical_specialtyCerebroNeurogenesiseducationBiologyBromodesoxiuridina:Anatomy::Nervous System::Neuroglia::Microglia [Medical Subject Headings]Triglicéridoslcsh:RC321-571Ácidos oléicosRatas03 medical and health sciencesCellular and Molecular NeuroscienceInternal medicineHipocampomedicineCaspasa 3:Anatomy::Nervous System::Central Nervous System::Brain::Limbic System::Hippocampus [Medical Subject Headings]:Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Growth Processes::Cell Proliferation [Medical Subject Headings]lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biologyPalmitoylethanolamide:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Neurotransmitter Agents::Endocannabinoids [Medical Subject Headings]:Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Hydrolases::Amidohydrolases [Medical Subject Headings]Cannabinoids:Anatomy::Cells::Neuroglia::Astrocytes [Medical Subject Headings]Peso corporalEnergy metabolism:Anatomy::Nervous System::Central Nervous System::Brain [Medical Subject Headings]:Anatomy::Nervous System::Central Nervous System::Brain::Limbic System::Hypothalamus [Medical Subject Headings]URB597:Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Death [Medical Subject Headings]:Diseases::Pathological Conditions Signs and Symptoms::Pathologic Processes::Gliosis [Medical Subject Headings]:Chemicals and Drugs::Organic Chemicals::Amines::Amino Alcohols::Ethanolamines [Medical Subject Headings]Muerte celular:Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Death::Apoptosis [Medical Subject Headings]:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Rodentia::Muridae::Murinae::Rats [Medical Subject Headings]EndocrinologyURB597chemistryGliosisnervous systemGlucosaCannabinoidEnergy Metabolism:Chemicals and Drugs::Organic Chemicals::Amides::Benzamides [Medical Subject Headings]HipotálamoÁcidos palmíticos030217 neurology & neurosurgeryNeuroscienceFrontiers in Cellular Neuroscience
researchProduct

A low repeat length in oligodendrocyte chromatin

1985

Abstract: The behavior of oligodendrocyte chromatin after micrococcal nuclease digestion of nuclei was assayed in brains of rats of four different ages. During oligodendrocyte differentiation, a decreasing sensitivity of the chromatin to enzymatic attack was observed. On the other hand, the nucleosomal repeat length showed a slight tendency to increase during development. It is worth noting that even the highest values reported here for “oligodendrocyte’ chromatin repeat lengths are significantly lower than 200 base pairs, the value previously reported by others for “non‐astrocytic glia.” Copyright © 1985, Wiley Blackwell. All rights reserved

Base pairCellular differentiationFluorescent Antibody TechniqueOligodendrocyte differentiationBiochemistryCellular and Molecular NeuroscienceSettore BIO/10 - BiochimicamedicineAnimalsMicrococcal NucleaseNucleosomeRepetitive Sequences Nucleic AcidElectrophoresis Agar GelGeneticsNucleosomal Repeat LengthbiologyAge FactorsOligodendrocyte differentiationDNAMolecular biologyChromatinOligodendrocyteNucleosomesRatsChromatinOligodendrogliamedicine.anatomical_structureLiverbiology.proteinSettore MED/26 - NeurologiaNucleosomal repeat lengthNeurogliaBrain StemMicrococcal nuclease
researchProduct

TMIC-49. POTASSIUM CHANNEL KIR4.1 AND GLUTAMINE SYNTHETASE ARE DYSREGULATED IN GLIOMA

2017

The potassium channel KIR4.1 (KCNJ10) and the glutamate catalyzing enzyme glutamine synthetase (GS) are highly expressed in glial cells of the central nervous system. Both glial proteins play important roles in the maintenance of neuronal activity and neurotransmission. Dysfunction of both proteins can result in altered neuronal excitability and may lead to excitotoxicity. We analyzed 35 snap frozen tissue blocks (glioblastoma [GBM], n=22; low grade astrocytoma (LGA), n=8; oligodendroglioma (OG), n=3; oligoastrocytoma, n=2). All glioma samples had a matching tissue specimen from both the tumor core and the adjacent normal-appearing infiltration zone. Molecular subtyping (MGMT, IDH1/2, 1p/19…

Cancer ResearchChemistryGlutamate receptorExcitotoxicitymedicine.diseasemedicine.disease_causePotassium channelAbstractsmedicine.anatomical_structureOncologyGlutamine synthetaseGliomaGene expressionCancer researchmedicineNeurogliaNeurology (clinical)Oligodendroglioma
researchProduct

Predetermined embryonic glial cells form the distinct glial sheaths of the Drosophila peripheral nervous system

2013

International audience; One of the numerous functions of glial cells in Drosophila is the ensheathment of neurons to isolate them from the potassium-rich haemolymph, thereby establishing the blood-brain barrier. Peripheral nerves of flies are surrounded by three distinct glial cell types. Although all embryonic peripheral glia (ePG) have been identified on a single-cell level, their contribution to the three glial sheaths is not known. We used the Flybow system to label and identify each individual ePG in the living embryo and followed them into third instar larva. We demonstrate that all ePG persist until the end of larval development and some even to adulthood. We uncover the origin of al…

Cell typeCell tracingCellular differentiation[SDV]Life Sciences [q-bio]Biology03 medical and health sciences0302 clinical medicineFlybowmedicineAnimalsDrosophila ProteinsGlial sheathsMolecular BiologyMitosis[SDV.BDD]Life Sciences [q-bio]/Development BiologyResearch Articles030304 developmental biologyProgenitorHomeodomain Proteins0303 health sciencesMicroscopy ConfocalHyperplasiafungiEmbryoCell DifferentiationAnatomyHypertrophyEmbryonic stem cellImmunohistochemistryCell biology[SDV] Life Sciences [q-bio]medicine.anatomical_structurePeripheral nervous systemNeurogliaDrosophilaPeripheral nervous systemNeuroglia030217 neurology & neurosurgeryCell-specific mitotic abilitiesDevelopmental Biology
researchProduct

In vivo reprogramming for tissue repair.

2015

Berninger and colleagues define milestones for in vivo reprogramming and discuss recent developments in reprogramming into pancreatic b-cells and neurons. Vital organs such as the pancreas and the brain lack the capacity for effective regeneration. To overcome this limitation, an emerging strategy consists of converting resident tissue-specific cells into the cell types that are lost due to disease by a process called in vivo lineage reprogramming. Here we discuss recent breakthroughs in regenerating pancreatic β-cells and neurons from various cell types, and highlight fundamental challenges that need to be overcome for the translation of in vivo lineage reprogramming into therapy.

Cell typeLineage (genetic)Cell- and Tissue-Based TherapyAcinar CellsBiologyIn vivoInsulin-Secreting CellsmedicineHumansRegenerationCell LineagePancreasNeuronsBrain DiseasesRegeneration (biology)BrainPancreatic DiseasesTranslation (biology)Cell DifferentiationCell BiologyTissue repairCellular ReprogrammingCell biologymedicine.anatomical_structurePancreasReprogrammingNeurogliaNature cell biology
researchProduct